Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Oncologic Drugs Advisory Committee
May 9-10, 2007
Peter Adamson, M.D.
• Acknowledgement and Consent (pdf)
Stephen George, Ph.D.
• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pdf)
David Harrington, Ph.D.
• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pd)
Maha Hussain, M.D. (Added 1 pm)
• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pd)
Page updated:
April 24, 2007
|